Innovation in Pharmaceutical Biotechnology [electronic resource]: Comparing National Innovation Systems at the Sectoral Level /
Organisation for Economic Co-operation and Development.
Organisation for Economic Co-operation and Development.
Paris : OECD Publishing,
2006.
This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries - Belgium, Finland, France, Germany, Japan, the Netherlands, Norway and Spain. The report summarises the results of in-depth studies, providing a comparative analysis of participating countries' performance in science and innovation in biopharmaceuticals. It highlights specific characteristics of the national biopharmaceutical innovation systems in terms of their international openness and the specific role of demand-side factors in the innovation process. Major systemic failures affecting the functioning of the biopharmaceutical innovation systems are identified. Based on rich evidence, the report draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.
"The pharmaceutical biotechnology case study comprised eight participating countries: Belgium, Finland, France, Germany, Japan, the Netherlands, Norway and Spain"--Foreword.
Includes bibliographical references.
Structure, Dynamics and Performance in National Biopharmaceutical Innovation Systems -- Systemic Imperfections in Biopharmaceutical Innovation Systems -- Policy Implications -- Executive Summary -- Introduction -- Summary of Country Studies -- Comparison of Performance in National Biopharmaceutical Innovation Sy -- Openness of the Biopharmaceutical Innovation System.
This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries - Belgium, Finland, France, Germany, Japan, the Netherlands, Norway and Spain. The report summarises the results of in-depth studies, providing a comparative analysis of participating countries' performance in science and innovation in biopharmaceuticals. It highlights specific characteristics of the national biopharmaceutical innovation systems in terms of their international openness and the specific role of demand-side factors in the innovation process. Major systemic failures affecting the functioning of the biopharmaceutical innovation systems are identified. Based on rich evidence, the report draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.
Pharmaceutical biotechnology
Biotechnology